SCHEMBL11357012

SCHEMBL11357012

CNC(=NC#N)NCCSCc1[nH]cnc1Br

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.45
▸ CYP2D6 P10635 3/20 0.45
▸ HRH2 P25021 3/20 0.45
▸ LMNA P02545 2/20 0.45
▸ TSHR P16473 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ SLC22A2 O15244 1/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ GLA P06280 1/20 0.45
▸ ATP4A P20648 1/20 0.45
▸ APEX1 P27695 1/20 0.45
▸ PDE4A P27815 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ ADRA1A P35348 1/20 0.45
▸ ATP4B P51164 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ SLC47A2 Q86VL8 1/20 0.45
▸ SLC22A8 Q8TCC7 1/20 0.45
▸ SLC47A1 Q96FL8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cimetidine SCHEMBL15316685 0.87 HRH2 (0.48) CYP3A4CYP2D6HRH2LMNATSHR
Cimetidine SCHEMBL11283011 0.87 HRH2 (0.48) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL17240890 0.83 HRH2 (0.42) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL16398769 0.83 HRH2 (0.42) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL16408523 0.83 HRH2 (0.42) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL16408503 0.83 HRH2 (0.42) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11364278 0.82 SMN1; SMN2 (0.46) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL7653936 0.82 CYP3A4 (0.67) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL10413112 0.82 CYP3A4 (0.67) CYP3A4CYP2D6HRH2LMNATSHR
SCHEMBL11005661 0.81 CYP3A4 (0.51) CYP3A4CYP2D6HRH2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3950333-A HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 — — US claimed
US-4293699-A CONTAINING A BENZIMIDAZOLE OR 3-/5,6,7,8-TETRAHYDROIMIDAZO(1,5A)PYRIDINE, ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-10-06 — — US disclosed
US-4287198-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-09-01 — — US disclosed
US-4228291-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-10-14 — — US disclosed
US-4221802-A Pharmacologically active guanidine compounds for inhibiting H-2 histamine receptors SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1980-09-09 — — US disclosed
US-4154844-A ANTIHISTAMINE, GASTRIC JUICE ANTISECRETORY AGENTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-05-15 — — US disclosed
US-4137237-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1979-01-30 — — US disclosed
US-4104382-A (((THIAZOLYL-, ISOTHIAZOLYL- OR PYRIDYLALKYL)THIO)ALKYL)GUANIDINE SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1978-08-01 — — US disclosed
US-4070475-A THIOALKYL-, AMINOALKYL-, AND OXYALKYL- SUBSTITUTED GUANIDINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1978-01-24 — — US disclosed
US-4024271-A INHIBITORS OF HISTAMINE ACTIVITY SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-17 — — US disclosed
US-4022797-A PHARMACEUTICALS SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1977-05-10 — — US disclosed
US-4000302-A ANTIHISTAMINES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-12-28 — — US disclosed
US-3950333-A HISTAMINE INHIBITORS, OXYALKYL, THIOALKYL, AMINOALKYL DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (EN) 1976-04-13 — — US disclosed
Send feedback